PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended September 30, 2022.
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q2) and half year ended 30th September, 2022, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after the conclusion of the Board meeting.06-11-2022